A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00300885 · TERMINATED
Trial details
- NCT number
- NCT00300885
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-10-01
- Enrollment
- 926
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.